1. Home
  2. NSPR vs OAKU Comparison

NSPR vs OAKU Comparison

Compare NSPR & OAKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • OAKU
  • Stock Information
  • Founded
  • NSPR 2005
  • OAKU 2022
  • Country
  • NSPR Israel
  • OAKU Canada
  • Employees
  • NSPR N/A
  • OAKU N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • OAKU Blank Checks
  • Sector
  • NSPR Health Care
  • OAKU Finance
  • Exchange
  • NSPR Nasdaq
  • OAKU Nasdaq
  • Market Cap
  • NSPR 63.0M
  • OAKU 68.9M
  • IPO Year
  • NSPR N/A
  • OAKU 2023
  • Fundamental
  • Price
  • NSPR $2.72
  • OAKU $11.41
  • Analyst Decision
  • NSPR Strong Buy
  • OAKU
  • Analyst Count
  • NSPR 2
  • OAKU 0
  • Target Price
  • NSPR $4.75
  • OAKU N/A
  • AVG Volume (30 Days)
  • NSPR 27.8K
  • OAKU 10.5K
  • Earning Date
  • NSPR 03-05-2025
  • OAKU 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • OAKU N/A
  • EPS Growth
  • NSPR N/A
  • OAKU N/A
  • EPS
  • NSPR N/A
  • OAKU 0.07
  • Revenue
  • NSPR $6,821,000.00
  • OAKU N/A
  • Revenue This Year
  • NSPR $13.36
  • OAKU N/A
  • Revenue Next Year
  • NSPR $49.64
  • OAKU N/A
  • P/E Ratio
  • NSPR N/A
  • OAKU $158.54
  • Revenue Growth
  • NSPR 24.70
  • OAKU N/A
  • 52 Week Low
  • NSPR $1.81
  • OAKU $10.57
  • 52 Week High
  • NSPR $3.42
  • OAKU $11.43
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 47.01
  • OAKU 77.90
  • Support Level
  • NSPR $2.50
  • OAKU $11.37
  • Resistance Level
  • NSPR $2.83
  • OAKU $11.43
  • Average True Range (ATR)
  • NSPR 0.20
  • OAKU 0.00
  • MACD
  • NSPR -0.01
  • OAKU 0.00
  • Stochastic Oscillator
  • NSPR 41.54
  • OAKU 100.00

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About OAKU Oak Woods Acquisition Corporation

Oak Woods Acquisition Corp is a a newly-incorporated blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more target businesses.

Share on Social Networks: